Used in biomedical research to quantify levels of amyloid precursor-like protein 2 (APLP2) in human biological samples such as serum, plasma, cerebrospinal fluid, and tissue lysates. It supports studies on neurodegenerative diseases, particularly Alzheimer's disease, where APLP2 is involved in neuronal development and synaptic function. The kit enables high-throughput screening in clinical research and drug development by providing a sensitive and specific method to monitor APLP2 expression changes under various experimental or pathological conditions.